| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.14 | 0.02 |